eNauka - pregled

Pregled prema Autor von, Minckwitz Gunter

Prikaz rezultata 1 do 3 od 3
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2018Clinical comparison of the biosimilar ABP 980 and trastuzumab in early breast cancer: Results of the phase 3 LILAC study and justification for extrapolation across approved trastuzumab indicationsKolberg, Hans-Christian; Tomasevic, Zoran M; Demetriou, Georgia S; von, Minckwitz Gunter; Fujiwara, Yasuhiro; Ponomarova, O; Tesch, Hans; Santi, Patricia Xavier; Hanes, VladimirKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2018Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trialvon, Minckwitz Gunter; Colleoni, Marco A; Kolberg, Hans-Christian; Morales, Serafin; Santi, Patricia Xavier; Tomasevic, Zorica I  ; Zhang, Nan; Hanes, VladimirNaučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2018PIK3CA alterations and benefit with neratinib after trastuzumab-based adjuvant therapy in early-stage HER2+breast cancer: Correlative analyses of the phase III ExteNET trialChia, Stephen KL; ...; Holmes, Frankie Ann; Ejlertsen, Bent; Delaloge, Suzette; Moy, Beverly; Iwata, Hiroji; von, Minckwitz Gunter; Mansi, Janine; Barrios, Carlos H;
Gnant, Michael; Evic, Zorica Toma; Denduluri, Neelima; Eparovic, Robert; Kim, Sung-Bae; Jakobsen, Erik Hugger; Harvey, Vernon; Robert, Nicholas; Smith, John II; Harker, Graydon; Lalani, Alshad S; Zhang, Bo; Eli, Lisa D; Buyse, Marc; (broj, koautora 25);
Konferencijski rad
Mp kategorija će biti prikazana naknadno.